Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 1,130 shares at $124.09 ($140K) on 2023-06-08, disclosed to the SEC on 2023-06-09.
Scheduled sale ($140k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.09 | 565 | $70K | 50.0% |
| 2 | $124.09 | 565 | $70K | 50.0% |
| Total | $124.09 avg | 1,130 | $140K | 100% |
| Filing → |
| MRNA | SELL | 2026-03-03 | $726K | — | Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |